With the acquisition of the French company KaLy-Cell SAS (KaLy-Cell), GBA Group expands its European pharmaceutical network. This is an important milestone for the GBA Group to offer a comprehensive service portfolio for national and international customers along the development phases of new safe medicines as well as chemicals for cosmetic and crop protection applications.

With Regulation (EU) 2021/1408 amending Regulation (EC) No. 1881/2006 setting maximum levels for certain contaminants in food, new maximum levels for tropane alkaloids (atropine and scopolamine) will come into force from September 1st, 2022 in the following products: processed cereal-based foods, unprocessed corn, buckwheat & millet and herbal teas.

Foods (except for the listed grain-based foods) that were lawfully placed on the market before September 1st, 2022, may be sold until their best-before or use-by dates.

GBA Group has developed a method for PFAS analysis. The accredited routine parameter of the GBA Group can detect a spectrum of 28 substances with highest sensitivity. The product groups meat, fish, eggs, fruit, vegetables, baby food and milk are covered and limits of determination below the specified maximum levels are achieved, so that even traces of the substances can still be detected.

From July 2022, new maximum levels for pyrrolizidine alkaloids (PA) in food will apply throughout Europe. These were already adopted by the Standing Committee of the EU Commission at the end of June 2020 and included in Regulation (EC) No. 1881/2006 setting maximum levels for certain contaminants in foodstuffs. Foods that were lawfully placed on the market before July 2022 may continue to be marketed until the end of 2023.

To address the rapidly growing need in scalable und fully automated Polymerase Chain Reaction (PCR) based Nucleic Acid Testing (NAT) LKF expands its assay portfolio with the cobas® 6800 system.